Jyothy Labs closes trading window for Q2FY27 results announcement
- Trading window closed for designated persons from October 1, 2026
- Closure lasts until 48 hours after Q2FY27 results publication
- Action taken under Clause 5 of Code of Conduct
- Notification filed with BSE and NSE on September 28, 2026

*this image is generated using AI for illustrative purposes only.
Jyothy Laboratories has closed the trading window for its designated persons and their immediate relatives effective October 1, 2026. This measure prevents insider trading ahead of the public disclosure of financial results.
The trading window will remain closed until the end of forty-eight hours following the date on which the company makes its financial results public. These results cover the second quarter and half-year ending September 30, 2026.
Regulatory compliance details
The decision was taken pursuant to Clause 5 of the Code of Conduct adopted by the company. This code regulates, monitors, and reports trading activities by designated persons to ensure market integrity and prevent misuse of unpublished price-sensitive information.
The company submitted this notification to both BSE Limited and National Stock Exchange of India Limited on September 28, 2026. The filing was signed by Shreyas Trivedi, Head Legal & Company Secretary.
Historical Stock Returns for Jyothy Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.56% | -2.60% | -10.65% | -11.40% | -40.19% | 0.0% |
How might the upcoming Q2 FY27 earnings report influence Jyothy Laboratories' stock volatility once the trading window reopens?
Will the company's guidance for the second half of FY27 reflect any strategic shifts in its FMCG portfolio amidst current market conditions?
How does this compliance action compare with recent trading window closures by other major Indian FMCG peers, and what does it suggest about sector-wide regulatory scrutiny?
































